List of Top 10 Human Rabies Vaccine Adjuvant Brands Popular in European and American Countries

June 26, 2024

Human Rabies Vaccine Adjuvant is a crucial component in enhancing the immune response to the rabies vaccine. Adjuvants help to stimulate the body's immune system, leading to a more effective and long-lasting immune response against the rabies virus. This adjuvant is essential in ensuring the vaccine's efficacy and protecting individuals from this deadly viral infection.

Imovax Rabies
Verorab
Rabipur
Changchun Zhuoyi Biological Co., Ltd
RabAvert
Rabies Vaccine BP

Imovax Rabies

Establishment time : 1978

website : www.sanofipasteur.com

Main Product : Imovax Rabies vaccine

Company Profile

Imovax Rabies is a vaccine produced by Sanofi Pasteur, a global pharmaceutical company established in 1978. The company is known for its high-quality vaccines and has a strong presence in the global market for Rabies Prevention.

Verorab

Establishment time : 1984

website : www.sanofipasteur.com

Main Product : Verorab rabies vaccine

Company Profile

Sanofi Pasteur, the manufacturer of Verorab, is a global healthcare company dedicated to preventing infectious diseases. With a strong presence in the vaccine market, Sanofi Pasteur is known for its high-quality products and commitment to public health.

Rabipur

Establishment time : Rabipur was established in 1996.

website : www.rabipur.com

Main Product : Rabipur specializes in the production of rabies vaccines.

Company Profile

Rabipur is a trusted name in the field of rabies prevention, offering safe and effective vaccines to protect individuals from this deadly virus. With a commitment to innovation and excellence, Rabipur continues to lead the way in the fight against rabies.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

RabAvert

Establishment time : RabAvert is a leading pharmaceutical company specializing in the production of rabies vaccines.

website :

Main Product : RabAvert's main product is its rabies vaccine, which is used to prevent the spread of rabies in both humans and animals.

Company Profile

Through ongoing research and development, RabAvert strives to improve the effectiveness and accessibility of its vaccines, ensuring the health and safety of individuals worldwide.

Rabies Vaccine BP

Establishment time : Not available

website :

Main Product : Rabies Vaccine BP

Company Profile

Not available

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326